Net shares · 365d
-500.0K
0 buy · 500.0K sell
Net value · 365d
-$260.0K
$0 in · $260.0K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
1
0 buy · 500.0K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
ELTP Exercise·M
EVP Operations
$0
2.5M sh
Own New
-
ELTP Exercise·M
EVP Operations
$75.0K
2.5M sh · $0.03
Own +139%
-
ELTP Sell·S
EVP Operations
$260.0K
500.0K sh · $0.52
Own -22%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Aug 25, 2025 | ELTP | Exercise M | 2.5M | $0 |
| Aug 25, 2025 | ELTP | Exercise M | 2.5M | $75.0K |
| Aug 22, 2025 | ELTP | Sell S | 500.0K | $260.0K |
Buy Sell Non-market (grant · exercise · gift)
About ELITE PHARMACEUTICALS INC /NV/
This profile aggregates every SEC Form 4 insider transaction reported by ELITE PHARMACEUTICALS INC /NV/ across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.